In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Encision Inc.

www.encision.com

Latest From Encision Inc.

Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q2 2009

Highlights from the Q2 2009 review of medical device and in vitro diagnostics/research dealmaking: Financings by medical device companies jumped an impressive 62% over Q1 to $847 million--primarily from private VC rounds that contributed over 90% of the total deal volume with 52 early- and late-stage transactions--indicating a possible rebound in fundraising. Medical device M&As, on the other hand, proved to be a disappointment with only ten deals raising $794 million, most of which was Covidien's $470 million cash purchase of Vnus Medical. Although there were no big mergers, some device firms instead turned to the strategic alliance as a way to gain inexpensive products and technologies. On the in vitro diagnostics/research side, financing activity captured over three times the previous quarter's dollars through 12 deals totaling $302 million, however, almost 80% of that amount was from Beckman Coulter's $239 million FOPO. VC rounds only averaged $6 million apiece, with early- and late-stage rounds together bringing in $43 million. M&A in this industry segment was almost non-existent with only two transactions adding up to $358 million, a mere third of Q1 M&A deal volume.
Medical Device

Intuitive Surgical Secures New Technologies

The economic meltdown that drove many publicly traded share prices into the ground promised to spark a shopping spree for strategic investors looking to score inexpensive assets. The deals largely haven't materialized, but Intuitive Surgical., with more than $800 million in cash reserves and investments, is certainly beginning to nibble. Over the past six months, Intuitive has signed three technology-sharing agreements and bought the assets of a fourth in pursuit of new technologies to help feed future products to sell along side-or potentially inside-its da Vinci surgical systems.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Electroscope Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Encision Inc.
  • Senior Management
  • Jack Serino, Pres. & CEO
    Roger Odell, VP, Bus. Dev.
  • Contact Info
  • Encision Inc.
    Phone: (303) 444-2600
    6797 Winchester Cir.
    Boulder, CO 80301
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register